Growth characteristics of infantile hemangiomas: implications for management

Linda C Chang1, Anita N Haggstrom, Beth A Drolet

  • 1Department of Dermatology, University of California, San Francisco, California, USA.

Pediatrics
|August 5, 2008
PubMed

Insights

Most infantile hemangioma growth occurs by 3 months, but specialist visits average 5 months. Early referral and observation are crucial for managing infantile hemangioma growth and outcomes.

Area of Science:

  • Pediatric Dermatology
  • Vascular Anomalies

Background:

  • Infantile hemangiomas (IH) present unique growth patterns, often not visible at birth.
  • Understanding IH growth dynamics is key for timely intervention and predicting outcomes.

Purpose of the Study:

  • To characterize infantile hemangioma growth patterns.
  • To compare IH growth with current referral timelines to specialists.

Main Methods:

  • Prospective cohort study across 7 pediatric dermatology practices.
  • Analyzed growth data from 526 infantile hemangiomas in 433 patients.
  • Compared growth stages and rates with clinical features and referral timing.

Main Results:

  • 80% of IH size achieved by a mean age of 3 months.
  • Deep and segmental IH subtypes showed later and longer growth periods.
  • Mean age of first specialist visit was 5 months, with factors like size and subtype predicting follow-up needs.

Conclusions:

  • Significant infantile hemangioma growth occurs before 5 months, the average age of first specialist visit.
  • Early recognition of IH growth characteristics and predictive factors is vital for clinical decision-making.
  • Close infant observation and prompt specialist referral within the critical early growth period are recommended.
Abstract

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...